Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,865 | 57,580 | 54,514 | 84,615 | 147,650 |
| Marketable Securities | 118,569 | 136,116 | 162,074 | 163,933 | 136,024 |
| Receivables | 4,557 | 4,434 | 5,437 | 59 | 341 |
| Inventories | 15,517 | 20,262 | 19,552 | 13,539 | 6,864 |
| TOTAL | $199,601 | $220,283 | $244,728 | $264,270 | $293,114 |
| Non-Current Assets | |||||
| PPE Net | 18,398 | 17,359 | 16,180 | 13,932 | 12,311 |
| Other Non-Current Assets | 317 | 319 | 312 | 356 | 322 |
| TOTAL | $18,715 | $17,678 | $16,492 | $14,288 | $12,633 |
| Total Assets | $218,316 | $237,961 | $261,220 | $278,558 | $305,747 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,742 | 8,158 | 9,032 | 9,432 | 9,515 |
| Accrued Expenses | 10,258 | 8,872 | 9,925 | 10,233 | 7,994 |
| Other current liabilities | 140 | 132 | 125 | 117 | 110 |
| TOTAL | $19,376 | $21,132 | $21,463 | $24,132 | $20,840 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,075 | 3,321 | 3,570 | 2,859 | 2,114 |
| Deferred Revenues | 4,236 | 3,970 | 2,381 | 4,350 | 3,221 |
| Other Non-Current Liabilities | 2,786 | 2,824 | 2,861 | 2,896 | 2,927 |
| TOTAL | $7,477 | $6,145 | $6,431 | $5,755 | $5,041 |
| Total Liabilities | $26,853 | $27,277 | $27,894 | $29,887 | $25,881 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,064 | 54,812 | 54,013 | 53,418 | 52,896 |
| Common Shares | 632,961 | 55 | 54 | 53 | N/A |
| Retained earnings | -441,555 | -418,732 | -389,451 | -366,976 | -332,167 |
| Other shareholders' equity | 57 | -4 | 181 | 3 | -21 |
| TOTAL | $191,463 | $210,684 | $233,326 | $248,671 | $279,866 |
| Total Liabilities And Equity | $218,316 | $237,961 | $261,220 | $278,558 | $305,747 |